DexCom

DexCom

Yahoo Finance • 18 hours ago

FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories' Libre Duo 10 Day Continuous Dual Glucose Ketone Moni... Full story

Yahoo Finance • 3 days ago

Abbott vs. DexCom: Which CGM Stock Is the Better Buy Now?

Abbott Laboratories ABT and DexCom DXCM are two of the most prominent players in the continuous glucose monitoring (CGM) space. Abbott has continued to enhance its continuous monitoring portfolio through product upgrades, expanded indicati... Full story

Yahoo Finance • 4 days ago

Oura is reportedly eyeing a September IPO that could value it at more than $16B

Oura, the smart ring maker, with offices in San Francisco and Finland, is reportedly planning to raise up $3 billion as soon as next month in a U.S. IPO that values the more than 900-person company at north of $16 billion, according to Blo... Full story

Yahoo Finance • 8 days ago

1 Healthcare Stock to Target This Week and 2 Facing Headwinds

1 Healthcare Stock to Target This Week and 2 Facing Headwinds Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from ele... Full story

Yahoo Finance • 12 days ago

1 Surging Stock Worth Your Attention and 2 We Question

1 Surging Stock Worth Your Attention and 2 We Question Exciting developments are taking place for the stocks in this article. They've all surged ahead of the broader market over the last month as catalysts such as new products and positiv... Full story

Yahoo Finance • 25 days ago

US Stock Market Today: S&P 500 Futures Rise On Stronger Sentiment And High-Rate Test

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. The Morning Bull - US Market Morning Update Monday, Aug, 3 2026 US stock futures are pointing h... Full story

Yahoo Finance • 27 days ago

Earnings scorecard: eight out of nine healthcare companies deliver EPS wins this week

Healthcare stocks (XLV [https://seekingalpha.com/symbol/XLV]) grabbed the spotlight this week as Wall Street digested earnings reports from companies including Centene (CNC [https://seekingalpha.com/symbol/CNC]), DexCom (DXCM [https://seek... Full story

Yahoo Finance • 28 days ago

Stocks Turn Mixed as Bond Yields Jump

The S&P 500 Index ($SPX) (SPY) today is down -0.02%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.24%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.17%.  September E-mini S&P futures (ESU26) are down -0.02%, and September E-m... Full story

Yahoo Finance • 28 days ago

Stock Indexes Supported as Amazon Earnings Bolster Tech Stocks

The S&P 500 Index ($SPX) (SPY) today is closed up +0.23%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.32%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.75%.  September E-mini S&P futures (ESU26) are up +0.17%, and September... Full story

Yahoo Finance • 28 days ago

Dexcom tweaks full-year outlook after reporting 13% growth in Q2

Dexcom has slightly raised its 2026 revenue outlook at the low-end after reporting Q2 revenue of around $1.3bn, indicative of a 13% uptick year-over-year (YoY). The continuous glucose monitoring (CGM) specialist now expects its 2026 reven... Full story

Yahoo Finance • 29 days ago

Dexcom lifts 2026 revenue outlook to $5.18B-$5.25B as it targets nearly 50% U.S. G7 15 Day conversion by year-end

Earnings Call Insights: DexCom, Inc. (DXCM) Q2 2026 MANAGEMENT VIEW * "Today, we reported second quarter revenue growth of 13% compared to the second quarter of 2025 and organic revenue growth of 12%." (President, CEO & Director Jacob... Full story

Yahoo Finance • 29 days ago

Stocks Rally on Stellar Microsoft Earnings and Chip Stock Strength

The S&P 500 Index ($SPX) (SPY) today is up +0.86%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.29%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +2.65%.  September E-mini S&P futures (ESU26) are up +0.84%, and September E-mini... Full story

Yahoo Finance • last month

Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls

Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as... Full story

Yahoo Finance • last month

Notable healthcare headlines for the week: Eli Lilly, Molina Healthcare, and Roche in focus

Wall Street's major averages aimed to go higher on Friday but closed mixed as oil prices declined. The benchmark S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-news%7Csection%3Amarket-news%7Csection_... Full story

Yahoo Finance • last month

1 Mid-Cap Stock to Target This Week and 2 We Find Risky

1 Mid-Cap Stock to Target This Week and 2 We Find Risky Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front... Full story

Yahoo Finance • 2 months ago

Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes

Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5. BURNABY, British Columbia, July 13, 2026--(BUSINESS WIRE)--Dexco... Full story

Yahoo Finance • 2 months ago

Investors’ Confidence in DexCom (DXCM) Rises as Growth Outlook Reassured

Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be downloaded here. The global equity market continued its rally in May, driven by accelerating AI infrastructure spend... Full story

Yahoo Finance • 2 months ago

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

SAN DIEGO, July 09, 2026--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. Management will hold a conference call... Full story

Yahoo Finance • 2 months ago

Heald Expands Access to AI-Powered Glucose Intelligence for Over-the-Counter CGM Users

Heald Consumers purchasing Dexcom Stelo or Abbott Lingo through Heald now receive complimentary access to AI-powered glucose insights ALPHARETTA, Ga., July 09, 2026 (GLOBE NEWSWIRE) -- Heald, a digital metabolic health platform, today an... Full story

Yahoo Finance • 2 months ago

Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM

By Karen Roman Glucotrack, Inc. (Nasdaq: GCTK) said the US Patent and Trademark Office issued a Notice of Allowance for a patent application which expands the intellectual property protecting the company's continuous blood glucose monitor... Full story